What instruments should we add to our toolbox for measuring the severity and control of eczema?

Affiliations

¹ Department of Dermatology, St George Hospital, Sydney, The George Institute of Global Health, University of NSW, Sydney, Australia.
² Department of Dermatology, Toulouse University, Toulouse, France.

Comment

D F Murrell et al. Br J Dermatol. 2021 Jul.

. 2021 Jul;185(1):13-14.

doi: 10.1111/bjd.20398. Epub 2021 Jun 11.

¹ Department of Dermatology, St George Hospital, Sydney, The George Institute of Global Health, University of NSW, Sydney, Australia.
² Department of Dermatology, Toulouse University, Toulouse, France.

No abstract available

Comment on

Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, Williams HC, Schmitt J, Gabes M, Howells L, Stuart BL, Grinich E, Pawlitschek T, Burton T, Howie L, Gadkari A, Eckert L, Ebata T, Boers M, Saeki H, Nakahara T, Katoh N. Thomas KS, et al. Br J Dermatol. 2021 Jul;185(1):139-146. doi: 10.1111/bjd.19751. Epub 2021 Feb 8. Br J Dermatol. 2021. PMID: 33393074 Free PMC article.

1. Schmitt J, Apfelbacher C, Spuls PI et al. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. J Invest Dermatol 2015; 135:24-30.
1. Prinsen CA, Vohra S, Rose MR et al. How to select outcome measurement instruments for outcomes included in a "Core Outcome Set" - a practical guideline. Trials 2016; 17:449.
1. Thomas KS, Apfelbacher CA, Chalmers JR et al. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting. Br J Dermatol 2021; https://doi.org/10.1111/bjd.19751.
1. Howells LM, Chalmers JR, Gran S et al. Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP). Br J Dermatol 2020; 183:524-36.
1. Simpson E, Eckert L, Gadkari A et al. Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis. BMC Dermatol 2019; 19:15.